Valuation : Compumedics Limited

Market Cap 50.94M 36.45M 31.44M 29.57M 26.94M 50.66M 3.46B 350M 136M 1.76B 137M 134M 5.83B P/E 2026
255x
P/E 2027 * 12.1x
Enterprise Value 50.94M 36.45M 31.44M 29.57M 26.94M 50.66M 3.46B 350M 136M 1.76B 137M 134M 5.83B EV / Sales 2026
0.85x
EV / Sales 2027 * 0.67x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 7.84%
1 day-5.88%
1 week-5.88%
Current month-5.88%
1 month+6.67%
3 months-9.43%
6 months-23.81%
Current year-28.36%
1 week 0.24
Extreme 0.235
0.27
1 month 0.22
Extreme 0.215
0.27
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-5.88%-5.88%-12.73%+33.33% 36.48M
-2.69%-4.40%+21.87%+7.77% 228B
-3.10%-4.19%+0.54%-22.09% 150B
-2.02%-0.70%-21.98%+18.96% 133B
-0.46%-3.57%-54.43%-10.33% 70B
-0.01%-0.14%+11.56%+18.80% 52.31B
+0.43%-1.01%-17.61%-14.19% 50.59B
-2.36%-3.13%+19.31%+22.98% 43.3B
-2.12%-2.08%+34.47%+44.42% 40.74B
-3.64%-2.21%-15.72%+45.34% 34.63B
Average -1.89%-1.48%-3.47%+14.50% 80.3B
Weighted average by Cap. -1.60%-1.59%-0.32%+6.10%

Financials

2026 2027 *
Net sales 60.3M 43.15M 37.22M 35.01M 31.89M 59.98M 4.09B 414M 161M 2.08B 162M 158M 6.91B 75.6M 54.09M 46.66M 43.89M 39.99M 75.19M 5.13B 519M 202M 2.61B 203M 199M 8.66B
Net income 2.3M 1.65M 1.42M 1.34M 1.22M 2.29M 156M 15.79M 6.14M 79.45M 6.18M 6.04M 263M 6M 4.29M 3.7M 3.48M 3.17M 5.97M 407M 41.18M 16.03M 207M 16.12M 15.77M 687M
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
02/09/26 $0.2400 -5.88% 90,057
01/09/26 $0.2550 0.00% 27,736
31/08/26 $0.2550 0.00% 168,340
28/08/26 $0.2550 0.00% 47,100
27/08/26 $0.2550 -3.77% 99,849
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2550AUD
Average target price
0.6500AUD
Spread / Average Target
+154.90%

Annual profits - Rate of surprise